STB
AZN icon

S&T Bank’s AstraZeneca AZN Stock Holding History

S&T Bank’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.67K Buy
+51
New +$9.59K ﹤0.01% 302
2025
Q3 		– Sell
-404
Closed -$56.5K – 487
2025
Q2 		$56.5K Hold
404
– – 0.02% 158
2025
Q1 		$59.4K Buy
+404
New +$58.5K 0.02% 152

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

S&T Bank's AZN Position: Q2 2026 in Review

S&T Bank opened a new position in AstraZeneca (AZN) in Q2 2026: 51 shares worth $9.67K. The stake represents ﹤0.01% of the portfolio and ranks #302 among its holdings. This is a return to the name: S&T Bank previously reported a position in AZN as recently as Q2 2025.

S&T Bank first reported a position in AZN in Q1 2025 and has held it in 3 quarters since. The position peaked at $59.4K in Q1 2025. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • S&T Bank held 51 shares of AstraZeneca worth $9.67K as of Q2 2026.
  • AstraZeneca was a new S&T Bank position in Q2 2026.
  • AstraZeneca made up ﹤0.01% of S&T Bank's portfolio in Q2 2026, its #302 holding.
  • S&T Bank first reported a position in AstraZeneca in Q1 2025 and has held it in 3 quarters since.
  • S&T Bank's AstraZeneca position peaked at $59.4K in Q1 2025.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on S&T Bank's 13F filing for Q2 2026, filed 12 Aug 2026.